CELK AB Stock Nasdaq Stockholm
Equities
SE0009189657
Advanced Medical Equipment & Technology
Sales 2024 * | 2.49B 229M 0 | Sales 2025 * | 2.89B 266M 0 | Capitalization | 3.15B 290M 0 |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.29M - | Net income 2025 * | 131M 12.04M - | EV / Sales 2024 * | 1.81 x |
Net Debt 2024 * | 1.36B 125M 0 | Net Debt 2025 * | 1.67B 153M 0 | EV / Sales 2025 * | 1.67 x |
P/E ratio 2024 * |
223
x | P/E ratio 2025 * |
24
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.54% |
Latest transcript on CELK AB
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | Nov. 19 | |
Erik Gatenholm
FOU | Founder | 35 | 15-02-28 |
Director of Finance/CFO | 39 | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
CHM | Chairman | 79 | 22-04-25 |
John Mackay
BRD | Director/Board Member | 61 | 22-12-31 |
Director/Board Member | 68 | 19-12-17 |
1st Jan change | Capi. | |
---|---|---|
+8.78% | 219B | |
+8.24% | 187B | |
+11.16% | 134B | |
+26.12% | 101B | |
+0.30% | 62.27B | |
+16.21% | 52.82B | |
-1.63% | 47.49B | |
-1.11% | 40.79B | |
+12.16% | 39.35B |